AstraZeneca’s COVID-19 vaccine is ineffective against the South African virus strain, study shows
According to a Phase 1b-2 trial published in the New England Journal of Medicine, the two-dose vaccine COVID-19 developed by Oxford University / AstraZeneca Plc (NASDAQ: AZN) was ineffective agains…
